RIPK3 and neoplasm: Our findings indicate that CH25H and its metabolite, 25HC, which are elevated in tumor‐infiltrating MDSCs, upregulate the expression of ARG1 and enhance immunosuppressive activity by inhibiting the STING–TBK1–RIPK3 signaling axis.